NFKB1 and malignant colon neoplasm: Previous studies have shown that inhibition of NF-κB signalling increases sensitivity of HTC15 human colon cancer cells to the chemotherapeutic daunomycin by modulating drug uptake (Bentires-Alj et al, 2003).